Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.23
+0.13000.99%
Post-market: 13.230.00000.00%16:10 EDT
Volume:410.78K
Turnover:5.39M
Market Cap:205.26M
PE:-4.15
High:13.28
Open:13.00
Low:12.90
Close:13.10
52wk High:16.77
52wk Low:11.95
Shares:15.52M
Float Shares:11.14M
Volume Ratio:0.63
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1910
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:-3.27
PE(LYR):-4.15

Loading ...

Novartis completes acquisition of Avidity Biosciences

TIPRANKS
·
Feb 27

Why Is Avidity Biosciences Stock (RNA) Down Today?

TIPRANKS
·
Feb 27

Novartis completes Avidity Biosciences acquisition for $72 a share

Reuters
·
Feb 27

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

GlobeNewswire
·
Feb 27

S&P 500 Futures Decline In Premarket Trading; Avidity Biosciences, Duolingo Lag

Dow Jones
·
Feb 27

N4 Pharma Plans Rebrand to Thalia Therapeutics to Reflect RNA-Focused Strategy

TIPRANKS
·
Feb 27

Avidity Shareholders Approve Novartis Merger and Spin-Off

TIPRANKS
·
Feb 27

Avidity Biosciences Inc. Held Special Stockholder Meeting

Reuters
·
Feb 27

Avidity Biosciences to Present at 2026 MDA Clinical & Scientific Conference

Reuters
·
Feb 27

Press Release: Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

Dow Jones
·
Feb 26

Avidity Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 25

GSK Signs Exclusive Global Licensing Agreement With Frontier Biotech for RNA Therapeutics

MT Newswires Live
·
Feb 24

Wave Life Sciences: Asymmetric Upside from Obesity and AATD RNA Editing Catalysts Supports Buy Rating

TIPRANKS
·
Feb 24

Avidity posts FY 2025 net loss of USD 684.6 million (+112%)

Reuters
·
Feb 24

Avidity Biosciences Advances Toward Novartis Merger Completion

TIPRANKS
·
Feb 23

Avidity Biosciences Delays Stockholder Meeting Ahead of Spin-Off, Novartis Merger

MT Newswires Live
·
Feb 23

Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

GlobeNewswire
·
Feb 23

Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026

GlobeNewswire
·
Feb 23

Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
Feb 23

Avidity Biosciences Delays Shareholder Meeting Until Feb. 26

Reuters
·
Feb 23